Alternatives to Elements

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Develops a computational model of the human body for drug discovery and development.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

Personalized nutrition and metabolic health platform using gut microbiome and AI.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

Scent-based multi-cancer early detection screening test using AI and bio-detectors.

BiotaX leverages an AI-powered microbial ecology platform to discover and engineer natural microbial communities for health, food, and climate applications.

Develops AI-powered decision support tools for personalized medical data interpretation and prediction.

Biotechnology company personalizing medical cannabis treatment using metabolic biomarker analysis.

Integrates scientific big data with patient medical records for personalized disease models and AI-driven insights.

A medical platform connecting patients and physicians with genetic expertise.

Transforming healthcare by turning scientific fiction into scientific facts.

Microbiome technology platform for developing novel therapeutics.

A molecular diagnostics company focused on integrating genomics with personalized therapeutic approaches for cancer.

Advanced diagnostics for preventative health and personalized cancer treatment using AI and genomics.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

AI platform for discovering complex multi-omics signatures for personalized medicine.

Personalized computational drug screening for rare diseases using patient genetics and automation.

Developing a miniaturized catheter-mounted axial flow-pump for mechanical circulatory support of the left ventricle.

AI-powered platform for cancer diagnostics in digital pathology.

AI-powered spatial biology platform for precision medicine and drug development.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

AI-driven drug discovery platform accelerating breakthrough scientific research.

AI-powered IVF clinic solutions for digitization and automation.

Comprehensive whole-genome monitoring for cancer recurrence and progression.

Ukko is developing novel food allergy and disorder treatments using advanced immunology and plant science.

AI-powered personalized screening for early disease detection using non-invasive methods.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

Develops AI-driven, real-time intraoperative imaging for early lung cancer diagnostics and treatment.

Predicting personalized drug combinations for cancer patients based on altered protein networks.

Radiaction Medical revolutionizes radiation protection for interventional medical teams with innovative, user-independent shielding solutions.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.

Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.

AI-powered platform for autonomous, point-of-care interpretation of fundus images for diabetic retinopathy.

Sweetch is a digital therapeutics company leveraging AI and emotional intelligence for hyper-personalized patient engagement.

Developing AI-driven solutions for optimizing chronic condition treatment efficacy and tolerance.

Harnessing genetic data for digital insights in rare and germline disorders.

Leveraging digital twins for real-time, individualized in-patient treatment optimization.

Develops a novel device for long-lasting sealing and fixation in endovascular aneurysm repair.

Digital therapeutics company focused on chronic pain management through personalized care.

MDacne is a mobile app that uses AI-powered computer vision for real-time acne analysis and provides personalized treatment.

Neurolief develops proprietary digital therapeutics neuromodulation technology to treat neurological and neuropsychiatric disorders like migraine and depression.

AI agents that automate healthcare administrative workflows, improving efficiency and patient care.

Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.

Designs and creates novel enzymes for sustainable and cost-effective bioproduction.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

TechsoMed develops ultrasound-based real-time monitoring systems for thermal ablation procedures, enhancing safety and efficacy.

Nevia Bio is a femtech startup focused on early detection of women's health conditions.

A platform for functional, integrative, and longevity medicine.

AI-powered platform to enhance fertility treatment success rates and patient experience.

Provides personalized medical research and insights for patients with complex conditions.